These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
74 related items for PubMed ID: 506549
21. Cytotoxic effects of pyocin S2 produced by Pseudomonas aeruginosa on the growth of three human cell lines. Abdi-Ali A, Worobec EA, Deezagi A, Malekzadeh F. Can J Microbiol; 2004 May; 50(5):375-81. PubMed ID: 15213746 [Abstract] [Full Text] [Related]
23. Serological and pyocin typing and antibiotic sensitivity of Pseudomonas aeruginosa strains. Del Piano M, La Palombara P, Picci A, Nicosia R. Microbiologica; 1986 Apr; 9(2):253-8. PubMed ID: 3086671 [Abstract] [Full Text] [Related]
24. [Production of pyocins and their use in the typing of Pseudomonas aeruginosa]. Wilhelms D. Z Gesamte Hyg; 1977 Sep; 23(9):672-5. PubMed ID: 412335 [No Abstract] [Full Text] [Related]
27. A Pseudomonas pyocin typing method applicable to the clinical laboratory. Barnes WG, Gitta PS. Am J Med Technol; 1979 Aug; 45(8):688-91. PubMed ID: 114048 [Abstract] [Full Text] [Related]
28. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Martínez-Solano L, Macia MD, Fajardo A, Oliver A, Martinez JL. Clin Infect Dis; 2008 Dec 15; 47(12):1526-33. PubMed ID: 18990062 [Abstract] [Full Text] [Related]
31. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO. Int J Antimicrob Agents; 2006 Mar 15; 27(3):224-8. PubMed ID: 16464562 [Abstract] [Full Text] [Related]
32. [Characterization of Pseudomonas aeruginosa isolates from intensive care units by sero-, lyso- and pyocin typing]. Breunung M, Baumann B, Weber C, Soltau U. Z Gesamte Hyg; 1986 Oct 15; 32(10):611-4. PubMed ID: 3101296 [No Abstract] [Full Text] [Related]
33. Use of DNA fingerprinting in decision making for considering closure of neonatal intensive care units because of Pseudomonas aeruginosa bloodstream infections. Schutze GE, Gilliam CH, Jin S, Cavenaugh CK, Hall RW, Bradsher RW, Jacobs RF. Pediatr Infect Dis J; 2004 Feb 15; 23(2):110-4. PubMed ID: 14872174 [Abstract] [Full Text] [Related]
34. [Modified procedure for pyocin typing of Pseudomonas aeruginosa (author's transl)]. Bauernfeind A, Petermüller C, Burrows JR. Zentralbl Bakteriol Orig A; 1978 Apr 15; 240(2):271-8. PubMed ID: 418604 [Abstract] [Full Text] [Related]
35. Predominance of Pseudomonas aeruginosa serotype 11, pyocin types 1 and 10 in Singapore. Poh CL, Yap EH, Tay L, Loh GK, Thong TW. Singapore Med J; 1986 Apr 15; 27(2):135-9. PubMed ID: 3092359 [No Abstract] [Full Text] [Related]
36. Isolation, purification and characterization of a pyocin. Faydi YR, Nabbut NH. Ann Microbiol (Paris); 1978 Apr 15; 129(3):313-22. PubMed ID: 96719 [Abstract] [Full Text] [Related]
37. Relationship of antibiotic resistance phenotype to the R-pyocin susceptibility pattern in clinical isolates of Pseudomonas aeruginosa. Tzouvelekis LS, Tumah H, Malliara K, Legakis NJ. J Chemother; 1989 Aug 15; 1(4):226-30. PubMed ID: 2509643 [Abstract] [Full Text] [Related]
38. Complex typing of Pseudomonas aeruginosa strains isolated in an intensive care unit [a note]. Barcs I, Jánosi L, Szentmihályi A, Balázs K. Acta Microbiol Hung; 1990 Aug 15; 37(3):319-23. PubMed ID: 2129258 [Abstract] [Full Text] [Related]
40. Evaluation of a typing scheme for group A streptococci based upon bacteriocin-like inhibitor production. Tagg JR, Martin DR. Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May 15; 257(1):60-7. PubMed ID: 6380156 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]